Profile picture

Doctor Francesco Melillo

IRCCS San Raffaele Scientific Institute, Milan (Italy)
Follow
Logo ESC

Contributor content

Impact on outcome of different etiologies, baseline degree and improvement of mitral regurgitation in patients with aortic stenosis who underwent transcatheter aortic valve replacement
Presentation
Impact on outcome of different etiologies, baseline degree and improvement of mitral regurgitation in patients with aortic stenosis who underwent transcatheter aortic valve replacement
Two-years outcome of patients with heart failure and severe left ventricular dysfunction treated with ivabradine and low doses of beta-blocker
Presentation
Two-years outcome of patients with heart failure and severe left ventricular dysfunction treated with ivabradine and low doses of beta-blocker
One-year clinical outcome and predictors of adverse events after percutaneous coronary intervention in elderly patients
Presentation
One-year clinical outcome and predictors of adverse events after percutaneous coronary intervention in elderly patients
Real-world single tertiary-care multidisciplinary experience with dabigatran, apixaban, rivaroxaban and warfarin in patients with renal failure and concomitant NVAF.
Presentation
Real-world single tertiary-care multidisciplinary experience with dabigatran, apixaban, rivaroxaban and warfarin in patients with renal failure and concomitant NVAF.
Clinical outcome of low-dose regimen of dabigatran, apixaban, rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation: a single tertiary care multidisciplinary experience.
Presentation
Clinical outcome of low-dose regimen of dabigatran, apixaban, rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation: a single tertiary care multidisciplinary experience.

ESC 365 is supported by